Matthew Fedor, MD
Clinical Cardiac Electrophysiology · Salem, ORNPI 1235225624
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.1% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Abbott at 27.8% of the total. Reporting peaked in 2019 at $2,596 and has fallen 96.9% since, to $80 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in OR, where the typical reported total is $7,720.
Across 135 payments — averaging $40.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$1K
- Boston Scientific$769
- Biosense Webster, Inc.$565
- Biotronik Inc.$539
- Amgen$154
- plus $875 from 15 others
Across 4 payments — averaging $528.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$2K
What the payments were for
- Consulting fees$4288%
- Travel & lodging$200%
- Food & beverage$4,95791%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 24 | $1,513 |
| Medtronic(3 entities) | 23 | $1,026 |
| Boston Scientific | 13 | $769 |
| Biosense Webster, Inc. | 8 | $565 |
| Biotronik Inc. | 11 | $539 |
| Amgen | 6 | $154 |
| E.r. Squibb & Sons, L.L.C. | 10 | $149 |
| Pfizer | 3 | $123 |
| Sanofi-aventis U.S. LLC | 7 | $110 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $90 |
| Johnson & Johnson | 4 | $86 |
| Novartis | 6 | $70 |
| Amarin Pharma, Inc. | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 3 | $39 |
| Boehringer Ingelheim | 1 | $35 |
| Alnylam Pharmaceuticals Inc. | 2 | $27 |
| Irhythm Technologies, Inc. | 1 | $22 |
| Elutia, Inc. | 1 | $21 |
| AstraZeneca | 1 | $15 |
| Lundbeck LLC | 1 | $13 |
| Opsens Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,441 in reported general payments places this provider in the 35th percentile of 37 clinical cardiac electrophysiology providers in Oregon.
See all clinical cardiac electrophysiology providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 169 | $182,244 |
| XareltoRivaroxaban | 79 | $90,124 |
| EntrestoSacubitril/Valsartan | 32 | $31,718 |
| MultaqDronedarone Hcl | 11 | $20,586 |
| Propafenone Hcl ErPropafenone Hcl | 30 | $5,671 |
| Flecainide Acetate | 68 | $3,743 |
| Metoprolol Succinate | 219 | $3,234 |
| Amiodarone Hcl | 62 | $1,074 |
| SotalolSotalol Hcl | 44 | $957 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 14 | $599 |
| Losartan Potassium | 35 | $395 |
| ClopidogrelClopidogrel Bisulfate | 20 | $277 |
| Atenolol | 20 | $179 |
| Spironolactone | 19 | $131 |
| Metoprolol Tartrate | 14 | $114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $123 | $182,244169 claims |
| Johnson & JohnsonXarelto | $86 | $90,12479 claims |
| NovartisEntresto | $70 | $31,71832 claims |
| Sanofi-aventis U.S. LLCMultaq | $110 | $20,58611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 37 clinical cardiac electrophysiology providers in Oregon.
Other clinical cardiac electrophysiology in Salem
- Sandeep SahaSalem$52K
- Ashit PatelSalem$36K
- Wallace LaiSalem$8K
- Eric PutzSalem$91
- Robert FlorekHood River$376K
- Jeff HsingCorvallis$89K
- Nathaniel McConkeyPortland$56K
- Jonathan LowyBend$46K
- Edward ChengGresham$39K
- Michael Charles TanPortland$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.